|Matt Dattilo, CIO, Cubist Pharmaceuticals|
It’s an exciting time to be in the pharmaceutical information business.
I would like to invite you to attend IIR’s inaugural Data-Driven Drug Development (D4), taking place on January 28-29 in Philadelphia. As you may have heard, I have the honor of being the chairman for this groundbreaking event and I am truly excited for those in the industry like us to have this opportunity to collaborate on how to bridge the knowledge gap between R&D and IT.
Without a doubt, one of the things that really intrigued me about this program is that the sessions are led by THE leading big pharma executives in the industry. When you download the agenda, you’ll see sessions including:
• Angela Yochem, CTO of Astrazeneca will explain why AZ is on the information management bandwagon, reinventing IT to make it a strategic asset to the business
• Ramzi Najm, Allergan’s VP of Information Technology Management will divulge how he was able to get buy-in from the executive leadership for a data-driven approach to company operations
• Brian Ellerman, Head of Information Solutions at Sanofi-Aventis will discuss strategies to maximize external collaboration through IT
These issues aren’t being addressed anywhere else. For more information about D4, please visit the website.
Thank you very much and I look forward to seeing you in January in Philly!
All the best,
CIO, Cubist Pharmaceuticals
Chairperson, Data-Driven Drug Development
Share this article with your social network, just click below to share now!